Advancing Cancer Research Webinar by Science/AAAS

Basic research aimed at gaining a more complete understanding of cancer biology is increasingly driven by cell-based assays. Commonly used endpoint assays have inherent limitations, including the use of invasive dyes, labels, or over-expression of reporter proteins, which can affect cellular physiology or morphology. Additionally, endpoint data alone does not easily provide a comprehensive profile of cellular mechanisms.
Real-time, label-free cell analysis technology offers insight into a complex whole-cell response, leading to more physiologically relevant data that can offer a more complete phenotypic profile. In this webinar, a panel of experts will discuss their research and describe the use of label-free, real-time monitoring in their investigation of novel targets for cancer drug discovery.
Webinar viewers will:

• Learn how scientists are incorporating real-time, label-free cell analysis to advance their research.
• Hear about applications for monitoring cell adhesion as well as invasion and migration in real time.
• Discover how label-free technology can be an enabling tool for cellular analysis.
• Have an opportunity to ask the panelists questions–live!

Wednesday, November 3, 2010
12 noon Eastern, 9 a.m. Pacific, 4 p.m. GMT
Duration: 1hr

---

Participants:

• Anton Wellstein, M.D./Ph.D.
  Georgetown University
  Washington, DC
• Robert H. Shoemaker, Ph.D.
  National Cancer Institute-Frederick
  Frederick, MD
• Stuart Martin, Ph.D.
  University of Maryland School of Medicine
  Baltimore, MD

---

Sponsored by: